当前位置:首页 - 行情中心 - 南微医学(688029) - 财务分析

南微医学

(688029)

  

流通市值:130.87亿  总市值:130.87亿
流通股本:1.88亿   总股本:1.88亿

南微医学(688029)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润4.64亿元,每股收益2.41元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益380228.72万元,未分配利润156206.73万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产456659.81万元,负债76431.08万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入2,012,446,160.411,333,844,008.46620,078,643.582,411,468,385.36
营业总成本1,467,685,015.45958,202,375.17447,485,577.571,854,314,053.6
营业利润540,081,506.91371,678,707.04172,959,026.14554,669,145.48
利润总额542,246,606.61373,095,091.63173,708,520.78564,909,917.62
净利润464,032,872.96319,998,746.09147,454,778.74494,700,551.52
其他综合收益-1,088,120.39-2,329,147.63-4,059,448.592,085,032.26
综合收益总额462,944,752.57317,669,598.46143,395,330.15496,785,583.78
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计3,285,106,650.113,190,639,200.813,208,432,794.63,290,807,580.17
非流动资产合计1,281,491,410.031,225,062,309.341,168,995,225.071,101,865,430.05
资产总计4,566,598,060.144,415,701,510.154,377,428,019.674,392,673,010.22
流动负债合计688,839,737.98577,895,191.44518,072,344.28649,519,965.7
非流动负债合计75,471,081.7576,163,445.9475,801,905.0472,994,604.32
负债合计764,310,819.73654,058,637.38593,874,249.32722,514,570.02
归属于母公司股东权益合计3,731,107,640.053,693,869,584.93,721,325,228.243,611,919,944.6
股东权益合计3,802,287,240.413,761,642,872.773,783,553,770.353,670,158,440.2
负债和股东权益合计4,566,598,060.144,415,701,510.154,377,428,019.674,392,673,010.22
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计2,109,854,672.771,425,742,315.41671,676,490.272,547,213,926.11
经营活动现金流出小计1,728,198,034.921,152,100,440.22615,950,912.542,001,639,165.14
经营活动产生的现金流量净额381,656,637.85273,641,875.1955,725,577.73545,574,760.97
投资活动现金流入小计2,314,666,583.31,747,329,453.92564,273,452.242,888,406,394.6
投资活动现金流出小计2,369,981,632.581,768,361,005.43874,532,233.074,025,771,808.96
投资活动产生的现金流量净额-55,315,049.28-21,031,551.51-310,258,780.83-1,137,365,414.36
筹资活动现金流入小计---37,278,253.6
筹资活动现金流出小计246,597,988.32230,985,453.432,802,158.67151,772,528.81
筹资活动产生的现金流量净额-246,597,988.32-230,985,453.4-32,802,158.67-114,494,275.21
汇率变动对现金及现金等价物的影响-7,449,033.53-7,599,861.78-10,349,349.940,186,688.62
现金及现金等价物净增加额72,294,566.7214,025,008.5-297,684,711.67-666,098,239.98
期末现金及现金等价物余额1,281,557,227.561,223,287,669.34911,582,949.171,209,262,660.84
最新报告期:2024-11-11
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
兴业证券东楠,孙媛媛,黄翰漾3.113.804.622024-11-11
国盛证券杨芳,张金洋3.123.874.842024-11-07
浙商证券孙建3.123.904.682024-11-01
国泰君安丁丹3.073.694.362024-11-01
中金公司俞波,张琎3.213.77--2024-10-31
TOP↑